1
|
He L, Wang L, Li L, Liu X, Yu Y, Zeng X, Li H, Gu Y. A single-center randomized controlled trial observing the safety and efficacy of modified step-up graded Valsalva manoeuver in patients with vasovagal syncope. PLoS One 2018; 13:e0191880. [PMID: 29381726 PMCID: PMC5790265 DOI: 10.1371/journal.pone.0191880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2017] [Accepted: 01/07/2018] [Indexed: 11/19/2022] Open
Abstract
Non-pharmacological therapies, especially the physical maneuvers, are viewed as important and promising strategies for reducing syncope recurrences in vasovagal syncope (VVS) patients. We observed the efficacy of a modified Valsalva maneuver (MVM) in VVS patients. 72 VVS patients with syncope history and positive head-up tilt table testing (HUTT) results were randomly divided into conventional treatment group (NVM group, n = 36) and conventional treatment plus standard MVM for 30 days group (MVM group, n = 36). Incidence of recurrent syncope after 12 months (6.5% vs. 41.2%, P<0.01) and rate of positive HUTT after 30 days (9.7% vs.79.4%, P<0.01) were significantly lower in MVM group than in NVM group. HRV results showed that low frequency (LF), LF/ high frequency (HF), standard deviation of NN intervals (SDNN) and standard deviation of all 5-min average NN intervals (SDANN) values were significantly lower in the NVM and MVM groups than in the control group at baseline. After 30 days treatment, LF, LF/HF, SDNN, SDANN values were significantly higher compared to baseline in MVM group. Results of Cox proportional hazard model showed that higher SDNN and SDANN values at 30 days after intervention were protective factors, while positive HUTT at 30 days after intervention was risk factor for recurrent syncope. Our results indicate that 30 days MVM intervention could effectively reduce the incidence of recurrent syncope up to 12 months in VVS patients, possibly through improving sympathetic function of VVS patients.
Collapse
Affiliation(s)
- Li He
- Department of Cardiology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
| | - Lan Wang
- Department of Neurology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
| | - Lun Li
- Department of Cardiology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
| | - Xiaoyan Liu
- Department of Cardiology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
| | - Yijun Yu
- Department of Cardiology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
| | - Xiaoyun Zeng
- Department of Neurology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
| | - Huanhuan Li
- Department of Cardiology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
| | - Ye Gu
- Department of Cardiology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, Hubei province, China
- * E-mail:
| |
Collapse
|
2
|
Abstract
Vasovagal syncope, or the "common faint", is the most common cause of syncope. Although it is considered a benign condition, there is a significant economic burden and significant impact on quality of life in patients with recurrent syncope, particularly in older adults. Typical vasovagal syncope usually occurs in young adults, and can often be diagnosed on the basis of history, in the absence of structural heart disease. Atypical vasovagal syncope, which is more common in older adults, can be more difficult to diagnose, however. In atypical vasovagal syncope, there is often a short or absent prodrome, and amnesia for loss of consciousness is common and it can, therefore, often be misdiagnosed, for example as falls. A more standardized approach to the diagnosis and management of patients presenting with syncope or unexplained falls is required, and it is anticipated that the number of Syncope Units will increase. Treatment of vasovagal syncope is largely conservative; however, medical or device therapy may be required when syncope is severe and refractory to conservative treatment, as there is significant impact on quality of life and it can be associated with injury. The aim of this article is to provide an overview of the diagnosis and management of vasovagal syncope.
Collapse
Affiliation(s)
- R A Kenny
- From the Mercers Institute, St James's Hospital, Dublin, Ireland
| | - T McNicholas
- From the Mercers Institute, St James's Hospital, Dublin, Ireland
| |
Collapse
|
3
|
Schleifer JW, Shen W. Vasovagal syncope: an update on the latest pharmacological therapies. Expert Opin Pharmacother 2014; 16:501-13. [DOI: 10.1517/14656566.2015.996129] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|